Assessment of mycobacterial viability by RNA amplification.

Antimicrobial Agents and Chemotherapy
G M van der VlietP R Klatser

Abstract

We investigated whether the presence of intact RNA is a valuable indicator of viability of mycobacteria with Mycobacterium smegmatis. M. smegmatis was exposed to various concentrations of rifampin and ofloxacin suspended in broth for different periods of time. The NASBA nucleic acid amplification system was used because of its rapid, sensitive, and specific detection of 16S rRNA. During drug exposure, the viability of the mycobacteria, expressed by the number of CFU, was compared with the presence of 16S rRNA as determined by NASBA and with the presence of DNA coding for 16S rRNA as determined by PCR. Both NASBA and PCR were shown to have a detection limit of approximately 5 x 10(2) CFU/ml. The intensity of the NASBA signal corresponded well with the number of CFU, and the lack of NASBA signal coincided with a loss of viability, which was reached after 3 days of exposure to bactericidal concentrations of both drugs. The presence of mycobacterial DNA, as determined by the intensity of the PCR signal, and the viability of M. smegmatis were not related, but an increase in the number of cells and intensity of PCR signal correlated well. Bacterial viability may thus be assessed by a rapid, sensitive, and specific, and semiquantitati...Continue Reading

References

Mar 1, 1990·Journal of Clinical Microbiology·R BoomJ van der Noordaa
Aug 1, 1990·Journal of Clinical Microbiology·B BöddinghausE C Böttger
Jan 15, 1989·FEMS Microbiology Letters·H BercovierS Sela
Jan 1, 1989·Antimicrobial Agents and Chemotherapy·D C LeysenS R Pattyn
Sep 1, 1989·Journal of General Microbiology·R A HartskeerlP R Klatser
Dec 1, 1986·Journal of Clinical Microbiology·R J WallaceV Steingrube
Mar 1, 1985·Journal of Bacteriology·J E Clark-CurtissR Curtiss
Jul 1, 1983·Reviews of Infectious Diseases·W Wehrli
Oct 1, 1993·Applied and Environmental Microbiology·K L JosephsonI L Pepper
Oct 1, 1993·Journal of General Microbiology·G M van der VlietP R Klatser
Sep 9, 1993·The New England Journal of Medicine·M D Iseman
Sep 1, 1993·Journal of Clinical Microbiology·P W Andrew, I S Roberts
Jan 4, 1993·Journal of Immunological Methods·L F BarreraD Radzioch
Apr 1, 1993·Journal of Clinical Microbiology·R E HuebnerJ I Tokars

❮ Previous
Next ❯

Citations

Dec 16, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·O F OsmanP A Kager
Mar 20, 1998·Journal of Virological Methods·N ChadwickA Wakefield
Mar 1, 2002·Journal of Microbiological Methods·Vanda Dolabela de MagalhãesMarinês Dalla Valle Martino
Jul 23, 2002·Journal of Microbiological Methods·Gael FenhallsPhilip Bardin
Jun 17, 1997·International Journal of Food Microbiology·M UyttendaeleJ Debevere
Feb 27, 2003·Biosensors & Bioelectronics·Antje J BaeumnerJunhong Min
Sep 18, 2002·Journal of Applied Microbiology·L BentsinkJ M van der Wolf
May 26, 2006·Antimicrobial Agents and Chemotherapy·Steve AellenPhilippe Moreillon
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Benjamin L MakepeaceAlexander J Trees
Mar 3, 2010·The Journal of Bone and Joint Surgery. American Volume·Patrick F BerginRocky S Tuan
Feb 12, 2009·Future Microbiology·Claire Cenciarini-BordeBernard La Scola
Sep 14, 2010·Veterinary Immunology and Immunopathology·Rebecca M MitchellYnte H Schukken
May 1, 2008·Letters in Applied Microbiology·S J LahtinenS J Salminen
Dec 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P R Gangadharam
Oct 21, 2006·FEMS Immunology and Medical Microbiology·Benjawan PhetsuksiriPatrick J Brennan
Mar 8, 2019·Microbiology·Shravanthi S Kumar, Asit Ranjan Ghosh
Apr 16, 2004·Journal of Food Protection·John L McKillip, Maryanne Drake
Apr 18, 1998·Applied and Environmental Microbiology·G E SheridanB M MacKey
Apr 13, 2002·Analytical Biochemistry·Junhong Min, Antje J Baeumner
May 9, 1998·Journal of Clinical Microbiology·M KurabachewJ J Ryon
Jul 1, 1997·Journal of Bacteriology·G A Cangelosi, W H Brabant
Jan 16, 1999·Journal of Clinical Microbiology·T J HellyerK D Eisenach
Oct 1, 1996·Journal of Clinical Microbiology·L E DesjardinK D Eisenach

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.